Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts

Cell Growth and Differentiation

Volumn 13, Issue 8, 2002, Pages 387-395

  Samaniego, Felipe ^a   Young, Daniel ^a   Grimes, Cara ^a   Prospero, Vanessa ^a   Christofidou Solomidou, Melpo ^a   DeLisser, Horace M ^a   Prakash, Om ^a   Sahin, Aysegul A ^a   Wang, Suizhao ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA3 INTEGRIN; ISOPROTEIN; NEUTRALIZING ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; ANTIBODY; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SKIN GRAFT; SPINDLE CELL; ANIMAL; BLOOD; CANCER TRANSPLANTATION; CELL DIVISION; CELL LINE; DRUG ANTAGONISM; GENETICS; GRAFT SURVIVAL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; SKIN TRANSPLANTATION; SKIN TUMOR;

ANIMAL; ANTIBODIES; CELL DIVISION; CELL LINE, TRANSFORMED; ENDOTHELIAL GROWTH FACTORS; GRAFT SURVIVAL; HIV INFECTIONS; HIV-1; HUMAN; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MICE; NEOPLASM TRANSPLANTATION; SARCOMA, KAPOSI; SKIN NEOPLASMS; SKIN TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036024858     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men. Part 1. Epidemiologic results
2. Prevalence of Kaposi's sarcoma among patients with AIDS
3. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
4. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
5. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome
6. Clinical overview: Issues in Kaposi's sarcoma therapeutics
7. The challenge of designing clinical trials for AIDS-related Kaposi's sarcoma
8. Consideration of host-viral interactions in the pathogenesis of Kaposi's sarcoma
9. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice
10. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor
11. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells
12. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells
13. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
14. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
15. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 Tat-expressing transgenic mice
16. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
17. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells
18. Regulation of adhesion molecule expression in Kaposi's sarcoma cells
19. Nonrandom chromosome changes in Kaposi sarcoma: Cytogenetic and FISH results in a new cell line (KS-IMM) and literature review
20. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection
21. Immunopathogenesis of Kaposi's sarcoma
22. The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line
23. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin
24. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice
25. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules
26. Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo
27. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal anti-bodies, and synergy between anti-endoglin antibody and cyclophosphamide
28. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: Correlation with patient survival
29. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates
30. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients
31. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments
32. The vascular endothelial growth factor family of polypeptides
33. Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation
34. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
35. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development
36. VEGF receptor signal transduction
37. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
38. Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain
39. The role of αv integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
40. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin
41. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals
42. Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma
43. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients
44. Tissue specific expression of alternatively spliced murine PECAM-1 isoforms
45. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
46. Matrix metalloproteinases: Biologic activity and clinical implications
47. Vascular permeability factor, tumor angiogenesis and stroma generation
48. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis
49. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics
50. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
51. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
52. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells
53. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis
54. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
55. The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies
56. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells
57. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1)
58. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor
59. Expression and function of endothelial cell αv --------1integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras
60. Comparisons of Means